Purifying a full-length oligonucleotide product from impurities generated during synthesis is essential to ensure their functionality, safety, and efficacy in pharmaceutical and diagnostic applications. Due to their polyanionic nature, purifying oligonucleotides with high selectivity and resolution is challenging. Ion-pairing reversed-phase chromatography (IP-RP) has emerged as the dominant and preferred technique.
High pH/temperature stable and batch-tested columns with controlled levels of secondary interactions help quickly remove time-consuming bottlenecks. Waters XBridge Oligonucleotide BEH C18 Optimal Bed Density (OBD) Columns are the go-to-choice for preparative columns, delivering assured performance, consistent scalability, and high recovery purification of various oligos with complex chemical modifications.
For preparative columns with smaller aspect ratios, high pressure slurry packing with small particles often fails to achieve the desired bed density found in well-designed analytical columns. Excessive axial compression at the inlet can result in particle breakage, channeling, and reduced bed permeability. Thoughtfully designed OBD columns offer significant benefits, including longer column lifetime, improved efficiency, better peak shape, and lower back pressure.
Nucleic acids, including oligonucleotides are polyanionic (negatively charged) and as such readily adsorb metal oxide surfaces in stainless steel columns. Waters XBridge Premier Oligonucleotide BEH C18OBD Columns are built with hardware components modified to have an inert hybrid organic/inorganic silica-based surface chemistry that greatly reduces non-specific adsorption (NSA) of nucleic acids, thus enabling enhanced recovery and improved reproducibility for certain compounds that need to be isolated from a drug substance for further study. XBridge Premier Oligonucleotide BEH C18 OBD Columns also eliminate the need for column passivation/sample conditioning so you can start your fraction collection runs without delay.
Waters batch-certified Bridged Ethyl Hybrid (BEH) technology for oligonucleotides ensures extra performance, reproducibility, and scale-up for purification. High temperature and high pH are prevalent strategies for minimizing secondary interactions in oligonucleotide separation and purification. BEH particle technology withstands harsh conditions such as high pH, temp, and additives that usually are required for oligonucleotide analysis.
Batch-tested and QC-certified XBridge Oligonucleotide OBD Prep Columns provide extra assurance for reproducibility and method transfer, and support emerging purification needs for standard and new chemically diverse siRNAs, ASOs, and oligonucleotide reagents. Each batch of Oligonucleotide BEH C18 sorbent is QC tested and selected using Waters MassPrep Oligonucleotide Standard and a stringent resolution and peak tailing assessment from a triethylammonium acetate IP-RP separation. These carefully examined sorbents are available in 2.5 and 5 µm particle sizes as well as 130 and 300 Å pore sizes to give oligonucleotide chemists a range of versatile options to purify a variety of synthesis products.
XBridge and XBridge Premier Oligonucleotide OBD Prep Columns are packed with Waters BEH (Bridge Ethyl Hybrid) C18 hybrid silica particles and demonstrate remarkable column longevity under high pH and temperature conditions while maintaining outstanding separation performance. With careful care, Oligonucleotide BEH C18 Columns have been known to exceed 1,0000 injections without loss of efficiency or retention.
In preparative purifications, loading capacity is influenced by multiple parameters. Column efficiency, pore size, particle size, and method parameters play significant roles. Larger pore size columns allow for better mass transfer and sharper peak shapes of larger analytes. With their reduced surface area, they can exhibit lower loading capacity. Waters XBridge Oligonucleotide OBD Prep Columns are available in different pore sizes and a wide range of column I.D.s for predictable scalability and improved loading capacity.
High purity and quality oligonucleotide purification is critical to minimize the safety and efficacy concerns related to unwanted impurities in toxicological studies. The high-efficiency 2.5 µm XBridge Oligonucleotide OBD Prep Columns facilitating isolation of early and co-eluting impurities while maintaining chromatography profile without compromising high recovery.
Complementing our oligonucleotide reversed-phase columns, Waters provides a range of high-quality, lot-traceable analytical standards to facilitate system suitability testing, method development, and troubleshooting. These include our MassPREP Oligonucleotide Standard containing a 15–35mer oligodT ladder used to QC verify all Waters oligonucleotide branded columns, a 20mer ssDNA standard for benchmarking LC-MS/MS fragmentation and sequence analysis, a lipid-conjugated heavily modified antisense oligonucleotide (ASO), ssDNA, and dsDNA ladders, and more.
XBridge Oligonucleotide BEH C18 OBD Prep Columns are available with column guards. The column cartridges are packed with the same sorbent and can be used to prevent contamination and fouling of the prep columns resulting in longer column lifetime. Placing this guard assembly ahead of the prep column will provide longer column lifetimes and reduce purification costs.
CRISPR technology plays a critical role in gene editing modification. The technology utilizes single guide RNA (sgRNA) hence the significance of sgRNA purity for improved therapeutic accuracy and precision. The traditional on-market available 8 to 20 µm HPLC columns may not meet the need for drug safety and accuracy due to lack of required resolving power for isolating the impurities from target sequences.
The new batch-tested XBridge Oligonucleotide BEH C18, 300 Å, 5 µm Column improves separation efficiency and retention mechanism for larger nucleic acids such as sgRNA and related applications. The smaller particle sizes and optimized pore dimensions with 300 Å are applied to achieve new single pass, purity levels that are required for high-precision CRISPR applications.
CRISPR technology plays a critical role in gene editing modification. The technology utilizes single guide RNA (sgRNA) hence the significance of sgRNA purity for improved therapeutic accuracy and precision. The traditional on-market available 8 to 20 µm HPLC columns may not meet the need for drug safety and accuracy due to lack of required resolving power for isolating the impurities from target sequences.
The new batch-tested XBridge Oligonucleotide BEH C18, 300 Å, 5 µm Column improves separation efficiency and retention mechanism for larger nucleic acids such as sgRNA and related applications. The smaller particle sizes and optimized pore dimensions with 300 Å are applied to achieve new single pass, purity levels that are required for high-precision CRISPR applications.